Rift Valley Fever Innovation Lab: Rift Valley fever vaccine animal testing data at Sante Animale MCI in Mohammedia, Morocco
The objective of this study was to evaluate the safety and immunogenicity of a live, attenuated recombinant RVF arMP-12ΔNSm21/384 nucleotide deletion vaccine candidate in domestic ruminants. . The immunogenicity of 2 doses of 104 and 105 Tissue Culture Infectious Doses50% (TCID50) of the vaccine was assessed in of 2 …